Niagen Bioscience, Inc. (NAGE) Balance Sheet
As of 2026-06-30 (10-Q), Niagen Bioscience, Inc. (NAGE) reported total assets of $106.6M, total liabilities of $24.1M and shareholders' equity of $82.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $66.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NAGENiagen Bioscience, Inc.Follow NAGE — free
—
Price chart with a free account
- Market cap
- 192.3M
- P/E TTM
- 13.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Jan 15 | FY2015 Jan 16 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | — | — | — | — | — | 22.6 | 18.8 | 16.7 | 28.2 | 20.4 | 27.3 | 44.7 | 64.8 | 66.7 | |
| Receivables | 0.7 | 1.9 | 0.8 | 1.9 | 2.5 | 5.9 | 5.3 | 4.4 | 2.2 | 2.7 | 5.2 | 8.5 | 5.2 | 7.8 | 9.7 | 8.6 | |
| Inventory | 2.9 | 5.2 | 2.2 | 3.7 | 8.2 | 7.9 | 5.8 | 8.2 | 11.5 | 11.7 | 13.6 | 14.7 | 14.5 | 9.2 | 20.4 | 20.6 | |
| Current assets | 5.0 | 7.9 | 5.8 | 9.9 | 16.5 | 15.7 | 57.2 | 36.5 | 33.5 | 32.2 | 48.9 | 46.6 | 49.5 | 64.1 | 96.8 | 97.8 | |
| Total assets | 6.3 | 9.0 | 9.0 | 11.5 | 18.7 | 19.8 | 62.7 | 42.2 | 40.2 | 38.4 | 57.8 | 54.1 | 55.0 | 68.3 | 106.4 | 106.6 | |
| Current liabilities | 3.3 | 4.8 | 2.8 | 5.0 | 9.6 | 8.9 | 8.1 | 14.4 | 15.1 | 16.5 | 17.6 | 17.9 | 20.6 | 17.9 | 19.9 | 15.1 | |
| Long-term debt | — | — | — | 2.0 | 3.3 | 0.0 | — | — | — | — | — | — | — | — | — | — | |
| Short-term debt | — | 0.1 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.1 | — | — | — | — | — | — | — | — | |
| Total liabilities | — | 5.0 | 3.3 | 7.5 | 13.5 | 9.8 | 8.9 | 15.1 | 19.8 | 21.9 | 26.1 | 25.4 | 26.5 | 22.2 | 29.9 | 24.1 | |
| Shareholders' equity | 2.6 | 4.0 | 5.7 | 4.0 | 5.3 | 10.0 | 53.8 | 27.2 | 20.4 | 16.4 | 31.7 | 28.7 | 28.5 | 46.1 | 76.5 | 82.5 |
USD millions · SEC XBRL
Niagen Bioscience, Inc. — questions
- How much cash does Niagen Bioscience, Inc. have?
- $66.7M in cash and cash equivalents as of 2026-06-30.
- What are Niagen Bioscience, Inc.'s total assets?
- $106.6M as of 2026-06-30.
- What is Niagen Bioscience, Inc.'s shareholders' equity?
- $82.5M as of 2026-06-30.
Every figure on this page comes from Niagen Bioscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.